North America Ophthalmic Eye Droppers Market Size & Outlook
North America ophthalmic eye droppers market, 2018-2030 (US$M)
Related Markets
North America ophthalmic eye droppers market highlights
- The North America ophthalmic eye droppers market generated a revenue of USD 5,997.4 million in 2023.
- The market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
- In terms of segment, preserved multi-dose eye droppers was the largest revenue generating type in 2023.
- Preservative-free multi-dose eye droppers is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 5,997.4 million |
| Market revenue in 2030 | USD 9,064.2 million |
| Growth rate | 6.1% (CAGR from 2023 to 2030) |
| Largest segment | Preserved multi-dose eye droppers |
| Fastest growing segment | Preservative-free multi-dose eye droppers |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Unidose eye droppers, Preserved multi-dose eye droppers, Preservative-free multi-dose eye droppers |
| Key market players worldwide | AptarGroup Inc, Silgan Holdings Inc, Alcon Inc, Pfizer Inc, Bausch & Lomb Corp, Novartis AG ADR, AbbVie Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 44.7% of the global ophthalmic eye droppers market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,015.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ophthalmic Eye Droppers Market Scope
Ophthalmic Eye Droppers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America ophthalmic eye droppers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic eye droppers market will help companies and investors design strategic landscapes.
Preserved multi-dose eye droppers was the largest segment with a revenue share of 46.53% in 2023. Horizon Databook has segmented the North America ophthalmic eye droppers market based on unidose eye droppers, preserved multi-dose eye droppers, preservative-free multi-dose eye droppers covering the revenue growth of each sub-segment from 2018 to 2030.
In North America, the high occurrence of ophthalmic diseases like Dry Eye Disease (DED) and glaucoma, coupled with increased R&D spending, have resulted in the region's significant market share in 2023. To meet the increasing demand for dry eye treatments, manufacturers are expected to invest even more in R&D to develop better ophthalmic droppers that will improve patients' overall ocular health and quality of life.
The presence of major market players, including AptarGroup, Inc., Pfizer Inc., Bausch + Lomb Corporation, and AbbVie Inc., among others, has contributed to the U.S.'s dominant market share. The presence of key players ensures the rapid availability of new ophthalmic droppers in the region.
Reasons to subscribe to North America ophthalmic eye droppers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America ophthalmic eye droppers market databook
-
Our clientele includes a mix of ophthalmic eye droppers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America ophthalmic eye droppers market , including forecasts for subscribers. This continent databook contains high-level insights into North America ophthalmic eye droppers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America ophthalmic eye droppers market size, by country, 2018-2030 (US$M)
North America Ophthalmic Eye Droppers Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
